Publications by authors named "D Malvy"

Claim this Profile
E
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trial.
Clément R Massonnaud, Nathan Peiffer-Smadja, Pascal Poignard, Simon Jamard, François Goehringer, Denis Malvy

Clin Microbiol Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Health Across Humans, Animals, Plants, and Ecosystems: How Long Before Benefits Turn Harmful-and Harm Becomes Healing?
Patrick Giraudoux, Dominique Bourg, Thierry Lefrançois, Didier Bompangue, Dominique Angèle Vuitton, Denis Malvy

Open Forum Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradigm Shift Toward "One Health" Monitoring of -Borne Arbovirus Circulation in France: The 2022 Inaugural Spotlight on West Nile and Usutu Viruses in Nouvelle-Aquitaine.
Gaëlle Gonzalez, Camille Victoire Migné, Alexandre Duvignaud, Sandra Martin-Latil, Clément Bigeard, Denis Malvy

Open Forum Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial.
Hans-Kittil Viermyr, Kristian Tonby, Erica Ponzi, Sophie Trouillet-Assant, Julien Poissy, Denis Malvy

EBioMedicine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Xenomonitoring (MX) allows real-time surveillance of West Nile and Usutu virus in mosquito populations.
Clément Bigeard, Laura Pezzi, Raphaelle Klitting, Nazli Ayhan, Grégory L'Ambert, Denis Malvy

PLoS Negl Trop Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis